Barclays’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.23M | Buy |
|
|||||
|
2025
Q1 | $1.67M | Sell |
|
|||||
|
2024
Q4 | $3.03M | Buy |
|
|||||
|
2024
Q3 | $2.85M | Buy |
|
|||||
|
2024
Q2 | $765K | Sell |
|
|||||
|
2024
Q1 | $2.17M | Sell |
|
|||||
|
2023
Q4 | $4.78M | Buy |
|
|||||
|
2023
Q3 | $2.02M | Sell |
|
|||||
|
2023
Q2 | $6.13M | Buy |
|
|||||
|
2023
Q1 | $2.95M | Buy |
|
|||||
|
2022
Q4 | $2.9M | Sell |
|
|||||
|
2022
Q3 | $13.4M | Buy |
|
|||||
|
2022
Q2 | $212K | Buy |
|
|||||
|
2022
Q1 | $314K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $1K | Sell |
|
|||||
|
2019
Q1 | $20K | Buy |
|
|||||
|
2018
Q4 | $0 | Sell |
|
|||||
|
2018
Q3 | $57K | Buy |
|
|||||
|
2018
Q2 | $12K | Sell |
|
|||||
|
2018
Q1 | $41K | Buy |
|
|||||
|
2017
Q4 | $27K | Buy |
|
|||||
|
2017
Q3 | $3K | Sell |
|
|||||
|
2017
Q2 | $51K | Buy |
|
|||||
|
2017
Q1 | $25K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $126K | Buy |
|